Perspective Therapeutics Inc. (CATX)
NYSE · Healthcare
Perspective Therapeutics Inc. EPS 2020–2025
Perspective Therapeutics Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Perspective Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.25, a 0.00% increase year-over-year.
- Perspective Therapeutics Inc. annual eps for 2025 was $1.40, a 13.82% increase from 2024.
- Perspective Therapeutics Inc. annual eps for 2024 was $1.23, a 27.65% decrease from 2023.
- Perspective Therapeutics Inc. annual eps for 2023 was $1.70, a 240.00% increase from 2022.
- Perspective Therapeutics Inc. annual eps for 2022 was $0.50.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Perspective Therapeutics Inc. EPS — FAQ
Perspective Therapeutics Inc. (CATX) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Perspective Therapeutics Inc.'s eps?
Perspective Therapeutics Inc. (CATX) reported eps of $-1.40 for fiscal 2025.
Where can I see CATX's eps history?
The chart and table above show Perspective Therapeutics Inc.'s eps by year and by quarter, including the growth rate.